Massive Bio and GELL Announce Strategic Partnership to Advance Research, Medical Education, and Artificial Intelligence Across Latin America and the United States
AI Briefing
- • Massive Bio and GELL partner to advance research, medical education, and AI across Latin America and US.
- • Strategic alliance aims to improve clinical trials, physician education, and innovation in oncology and hematologic malignancies.
- • Partnership to drive progress in lymphoma research, patient care, and medical education in Latin America.
Context
Massive Bio and GELL have announced a strategic partnership. The partnership aims to advance research, medical education, and artificial intelligence in Latin America and the United States. Massive Bio is a leader in artificial intelligence-driven solutions for oncology and clinical trial matching.
The partnership between Massive Bio and GELL matters because it brings together a global leader in artificial intelligence with a prominent scientific network in Latin America. This collaboration will focus on clinical research, physician education, and innovation.
Advertisement